JP2016123765A - Chemical volatilizer - Google Patents

Abstract

Disclosed is a chemical volatilizer that can prevent a chemical from spilling even if the chemical volatilizer is a type of chemical volatilizer that uses a liquid absorbent wick.
A drug volatilizer according to the present invention has an opening in the upper part, a drug container containing a liquid drug, a liquid absorption core inserted into the opening of the drug container, and the drug container, A support that is attached to the attachment object, and the support includes a holding portion that holds the medicine container from outside in the radial direction with respect to the axial direction of the opening.
[Selection] Figure 1

Description

  The present invention relates to a chemical volatilizer.

  Conventionally, various forms of chemical volatilizers have been proposed in which chemicals such as fragrances are volatilized. Among them, a chemical volatilizer used in a place where vibration occurs, for example, in a vehicle, has been proposed. However, such a chemical volatilizer has a problem that a liquid chemical contained therein is spilled. For this reason, as a chemical volatilizer used in a vehicle, a gel type that does not use a liquid chemical or a membrane type that does not easily leak even by vibrations is often used. The membrane type is a type in which a gas-permeable membrane is used and a chemical volatilized through the membrane is released to the outside (for example, Patent Document 1).

JP 2014-94619 A

  However, the membrane type has a problem that the drugs that can be used are limited. For example, when used in a high-temperature environment, only chemicals that would volatilize in a short period of time could be used. Therefore, the following chemical volatilizers can be considered when using chemicals that can be used in various environments regardless of temperature. That is, a drug volatilizer of a type that supports a drug container on a support attached in the vehicle, sucks up the drug contained in the drug container with a liquid absorbent core, and discharges the volatilized drug to the outside. However, when this type of chemical volatilizer is used in a place where vibration is generated, there is a problem that the chemical container is detached from the support and the chemical spills. The present invention has been made to solve this problem, and provides a chemical volatilizer that can prevent the chemical from spilling even if the chemical volatilizer is a type of chemical volatilizer that sucks up a drug by a liquid absorbent core. The purpose is to do.

  The drug volatilizer according to the present invention has an opening in the upper part, a drug container in which a liquid drug is accommodated, a liquid absorption core inserted into the opening of the drug container, the drug container, and an attachment target A support that is attached to an object, and the support includes a holding unit that holds the drug container from outside in the radial direction with respect to the axial direction of the opening.

  According to this configuration, since the medicine container that contains the medicine is held on the support so as to be sandwiched from outside in the radial direction with respect to the axial direction of the opening, the medicine container vibrates in the radial direction, that is, in the lateral direction. Even if it receives, it can prevent that a chemical | medical agent container detaches | leaves from a support body. As a result, it is possible to prevent the medicine from spilling from the medicine container.

  In the drug volatilizer, the holding unit may be configured to hold any position of the drug container. For example, the drug container has a neck part in which the opening is formed and an outer shape that is larger than the neck part. A main body portion to which the neck portion is coupled, and the holding portion can be configured to hold the neck portion.

  At this time, a protrusion can be formed on the outer peripheral surface of the neck, and the holding portion can be engaged with a gap between the protrusion and the main body. By doing so, since the movement of the drug container in the axial direction is restricted, it is possible to prevent the drug container from being detached from the support body even when the drug container receives vibration in the axial direction, that is, the vertical direction.

  In each of the drug volatilizers, the support includes a first wall surface that covers the drug container from a side opposite to a side on which the holding unit is provided, and a first cover that covers the opening side into which the liquid absorption core is inserted. A cover provided with two wall surfaces is further provided, and the second wall surface can be configured to allow gas to pass therethrough.

  With this configuration, the following effects can be obtained. That is, the first wall surface can prevent the medicine container from being detached from the support body in the direction away from the holding portion. Further, the second wall surface can prevent the liquid absorbent core from being detached from the drug container. However, since the second wall surface is configured to allow gas to pass through, the volatilized drug can be released to the outside. Further, by providing the cover, the medicine container can be hidden. For example, if the first wall surface is decorated, the decorativeness of the product can be enhanced.

  In each of the drug volatilizers, the drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part, and the holding part includes the neck part. The support body is configured to hold a first support part in contact with an outer peripheral surface of the main body part at a vertical position corresponding to the center of gravity G of the drug container; and the first support part. And a second support portion that is connected and disposed below the first support portion with a gap therebetween.

  According to this configuration, the entire outer peripheral surface of the main body portion of the drug container is not supported by the support body, but the drug container is in contact with the first support portion of the support body, and is not spaced from the second support portion. Is open. Therefore, even if the medicine container receives vibration, at least part of the vibration can be absorbed by the gap with the second support portion. As a result, when receiving vibration, the medicine container can be prevented from being damaged by the impact from the support. Further, since the first support portion is in contact with the outer peripheral surface of the main body portion of the drug container at the vertical position corresponding to the center of gravity G of the drug container, the first support portion receives vibration (particularly the drug in the drug container). Even when the remaining amount is low), it can be prevented that the support is greatly shaken.

  In each of the drug volatilizers, the drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part, and the holding part includes the neck part. The support is configured to extend vertically, and is connected so that the holding portion extends toward the neck, and at least a part of the support contacts the side surface of the main body. A support part and a bottom face support part connected to the lower end part of the upper and lower support parts and extending so as to support the bottom face of the main body part in the same direction as the holding part can be provided.

  According to this configuration, since the main body portion of the drug container is supported so as to be sandwiched between the holding portion and the bottom surface support portion from above and below, when the drug container is attached to the support, if there is a vertical displacement, Since the main body portion hits the holding portion or the bottom surface supporting portion, it cannot be attached. Therefore, the bottom surface support portion functions as a guide for attaching the drug container to the support. In addition, since the main body portion is supported so as to be sandwiched between the holding portion and the bottom surface support portion from the vertical direction, it is possible to prevent the main body portion from being detached obliquely upward or obliquely downward.

  In each said chemical volatilizer, although a support body can also be directly attached to an attachment target object, the fixing | fixed part for attaching the said support body to an attachment target object can be provided, for example.

  Moreover, the said fixing | fixed part can be connected with respect to the said support body so that it can rotate, without stopping. The “rotation” according to the present invention includes not only rotation of 360 degrees or more but also rotation at an angle smaller than 360 degrees such as half rotation.

  According to this structure, when a support body receives a vibration, a support body rotates with respect to a fixing | fixed part. Therefore, for example, even if the attachment object is tilted, the support rotates so that the center of gravity of the support is positioned vertically below the connecting portion between the support and the fixed portion. Therefore, since the medicine container is maintained in a state in which the opening faces upward, the medicine can be prevented from spilling.

  Note that “without stopping” means that the support is completely stopped due to resistance during rotation of the support with respect to the fixed portion. Therefore, even if the object to be mounted is tilted and the support rotates relative to the fixed part, even if it receives some resistance, the center of gravity of the support does not stop between the support and the fixed part without stopping completely. If it moves below the connecting portion vertically, it is included in “without stopping” of the present invention.

  In each of the drug volatilizers, the drug container includes a bottom surface formed immediately below the opening and an outer peripheral surface extending upward from a peripheral edge of the bottom surface, and at least a part of a lower end portion of the liquid absorbent core is provided. , It can be configured to contact any one of the peripheral edges of the bottom surface.

  In such a drug container, the drug that has flowed to the bottom surface along the outer peripheral surface is likely to accumulate at the periphery of the bottom surface due to the surface tension, but as described above, at least a part of the lower end portion of the liquid absorbent core is placed on the bottom surface. If it abuts on one of the peripheral edges, the medicine accumulated on the peripheral edge on the side surface can be sucked up reliably. As a result, the medicine can be used up to the end.

  In each of the drug volatilizers, the drug container includes a bottom surface and an outer peripheral surface extending upward from a peripheral edge of the bottom surface, and the inner wall surface of the drug container has at least a part of the outer peripheral surface from the bottom surface. At least one ridge or groove extending across may be formed.

  When such protrusions or grooves are provided, the drug easily flows down to the bottom surface by passing through the protrusions or grooves. As a result, it becomes easy to suck up the medicine that has flowed down by the liquid absorbent core.

  In each of the drug volatilizers, the drug container includes a bottom surface and an outer peripheral surface extending upward from a peripheral edge of the bottom surface, and at least an inner wall surface of the drug container extends from the outer peripheral surface toward the opening. One ridge or groove may be formed.

  When such a ridge or groove is provided, for example, when the medicine container is turned upside down, the medicine is directed to the opening side along the outer peripheral surface, but the medicine is surely directed to the opening through the ridge or groove. Therefore, the liquid-absorbing core inserted into the opening can be surely sucked.

  According to the drug volatilizer according to the present invention, it is possible to prevent the drug from spilling.

It is a perspective view of the chemical volatilization device concerning this embodiment. It is a side view of FIG. It is a top view of FIG. It is the perspective view which looked at the chemical volatilizer of FIG. 1 from back. It is a front view of the medicine container concerning this embodiment. It is a bottom view of the chemical | medical agent container of FIG. It is the sectional view on the AA line of FIG. It is a perspective view of the support body in a 2nd position. It is a front view of FIG. It is a side view of the support body with which the chemical | medical agent container was mounted | worn in the 2nd position. It is a front view of FIG. It is a rear view of FIG. It is a side view of a fixed part. It is a front view which shows the usage method of the chemical volatilizer of FIG. It is sectional drawing which shows the other example of a chemical | medical agent container. It is sectional drawing which shows the other example of a chemical | medical agent container. It is a bottom view which shows the other example of a chemical | medical agent container.

  Hereinafter, one embodiment of a chemical volatilizer according to the present invention will be described with reference to the drawings. In the following, for convenience of explanation, the left side of FIG. 2 is referred to as the front side or the front side, and the right side is referred to as the back side or the rear side. Further, the vertical direction in FIG. 3 is referred to as a width direction. The other drawings will be described according to this direction. However, these directions do not limit the present invention.

  1 is a perspective view of a drug volatilizer according to the present embodiment, FIG. 2 is a side view of FIG. 1, FIG. 3 is a plan view of FIG. 1, and FIG. As shown in FIG. 1 to FIG. 4, the drug volatilizer according to the present embodiment includes a drug container 1 containing a liquid drug, a liquid absorption core 2 inserted into the drug container 1 and impregnated with the drug, It has the support body 3 which supports the chemical | medical agent container 1, and the fixing | fixed part 4 for attaching this support body 3 to an attachment target object. Hereinafter, each of these members will be described in detail.

<1. Drug container>
5 is a front view of the drug container, FIG. 6 is a bottom view of the drug container, and FIG. 7 is a cross-sectional view taken along line AA of FIG. As shown in FIGS. 5-7, the chemical | medical agent container 1 which concerns on this embodiment is equipped with the main-body part 11 of front view reverse triangle shape, and the neck part 12 connected with the upper end of this main-body part 11, These are integrally formed. The main body 11 has an internal space surrounded by a bottom surface 111, a pair of side surfaces 112a and 112b, a front surface 113, a back surface 114, and an upper surface 115, and a medicine is accommodated in the internal space. The bottom surface 111 is formed in a rectangular shape in plan view, and left and right edges (peripheries) are curved in a convex shape. The pair of side surfaces 112 extend from the left and right edge portions 1111 of the bottom surface 111 so as to be separated from each other obliquely upward. The front surface 113 and the back surface 114 extend upward from the front and rear edges of the bottom surface 111, respectively. The upper surface 115 is formed in a rectangular shape extending substantially horizontally so as to connect the upper end edges of the pair of side surfaces 112, the front surface 113, and the back surface 114. The neck 12 described above is connected to the center of the upper surface 115.

  The neck portion 12 is formed in a cylindrical shape having an opening 121 at the upper end, and is disposed immediately above the bottom surface 111. An annular protrusion 13 is formed at a position close to the upper surface 115 on the outer peripheral surface of the neck portion 12, and a holding portion described later is disposed in a gap between the protrusion 13 and the upper surface 115. A spiral male screw 14 is formed on the outer peripheral surface of the neck 12 above the protrusion 13. The male screw 14 is adapted to be screwed into a female screw of a cap (not shown). That is, a cap is attached to the neck portion 12 and is removed during use.

  The inner wall surface of the main body 11 is configured as follows. First, the protrusions 16 extending in the left-right direction are formed on the bottom surface 111 and the pair of side surfaces 112. The protrusion 16 extends in the vicinity of the center in the front-rear direction of the bottom surface 111 and the side surface 112 from the vicinity of the center in the vertical direction of one side surface 112a to the vicinity of the center in the vertical direction of the other side surface 112b through the bottom surface 111. . In addition, a groove is formed in the ridge 16 and extends along the ridge 16.

  A pair of protrusions 17 a and 17 b is also formed on the inner wall surface of the upper surface 115. Each of the protrusions 17a and 17b passes near the center of the upper surface 115 in the front-rear direction, extends from the vicinity of the left and right ends of the upper surface 115 toward the neck 12, and extends from the inner wall surface of the neck 12 to the edge of the opening 121. It extends upward. These protrusions 17a and 17b are also formed with grooves and extend along the protrusions 17a and 17b.

  The drug container 1 as described above can be formed of various materials, but can be formed of a resin material. In this case, for example, those formed in the state of being divided near the center in the front-rear direction (the formed ridges 16, 17a, 17b are also divided near the center in the front-rear direction) are bonded together, For example, the medicine container 1 can be formed by shaping the inner wall surfaces of the bottom surface 111 and the side surface 112 or attaching ridges after molding by an injection blow method or a direct blow method. Among the blow methods, in particular, when the drug container 1 is formed by the direct blow method, a cylindrical parison is used, the upper part of the parison is sandwiched between two molds, and the neck portion on which the male screw 14 and the protrusion 13 are formed. 12 is formed first, and then the portion below the molded neck 12 is squeezed with two molds, and the body 11 is molded while injecting air into the parison. When the portion below the neck portion 12 is sandwiched between two molding dies, the protrusions 16, 17a, and 17b can be molded by causing the resin material at the location where the molding dies come into contact with each other.

  Moreover, it is preferable to form the medicine container 1 with a transparent or translucent material so that the medicine inside can be visually recognized. As a liquid medicine accommodated in the medicine container 1, various kinds such as a known fragrance liquid, deodorant liquid, and aroma oil can be used depending on the application.

<2. Mounting structure for liquid core and drug container>
Next, the attachment structure to the liquid absorption core 2 and the medicine container 1 will be described. First, as shown in FIG. 7, an attachment member 5 for the liquid absorbent core 2 is attached to the drug container 1, and the liquid absorbent core 2 is attached to the drug container 1 via the attachment member 5. . The attachment member 5 includes a cylindrical attachment main body 51 that is press-fitted into the inner wall surface of the neck 12 of the medicine container 1, and a flange portion 52 that extends radially outward from the upper edge of the attachment main body 51. The liquid absorption core 2 is inserted into the mounting body 51. Moreover, the flange part 52 is arrange | positioned so that the opening periphery of the neck part 12 may be covered from upper direction.

  Further, a groove (not shown) extending in the vertical direction is formed on the inner wall surface of the mounting body 51, and when the liquid absorbing core 2 is inserted, the liquid absorbing core 2 and the mounting body 51 are inserted by this groove. A gap is formed between the two. This gap communicates the internal space of the medicine container 1 with the outside. Thereby, for example, when the drug container 1 is used in a high-temperature environment and the internal pressure of the drug container 1 increases, the air in the drug container 1 is discharged to the outside through the gap. On the other hand, if such a gap is not provided, the drug may be excessively pushed out through the liquid absorbent core 2 when the internal pressure rises.

  Next, the liquid absorbent core 2 will be described. The liquid absorption core 2 is formed in a columnar shape, and is inserted into the mounting body 51 in a state of being in close contact with the inner wall surface of the mounting body 51 as described above. And the length of the liquid absorption core 2 is set as follows. That is, the upper end portion of the liquid absorbent core 2 is set to protrude from the neck portion 12 when the lower end portion of the liquid absorbent core 2 contacts the bottom surface 111 of the drug container 1. At this time, the lower surface of the lower end portion 21 of the liquid absorbent core 2 is in contact with the bottom surface 111, and the peripheral edge of the lower end portion 21 is also in contact with the left and right edge portions 1111 of the bottom surface.

  The material which comprises the liquid absorption core 2 will not be specifically limited if it can absorb a chemical | medical agent and volatilize a chemical | medical agent from the part which protrudes from the neck part 12 to the exterior. For example, various materials such as paper and cloth can be used.

<3. Support>
Next, the support 3 will be described with reference to FIGS. 8 is a perspective view of the support in the second position, FIG. 9 is a front view of FIG. 8, FIG. 10 is a side view of the support with the drug container mounted in the second position, and FIG. FIG. 12 is a front view of FIG. However, in FIG. 12, the state which removed the fixing | fixed part is shown for convenience of explanation.

  As shown in FIGS. 8 to 12, the support 3 includes a support body (upper / lower support part) 31 that holds the medicine container 1 and a cover 32 that is attached to the support body 31 and covers the medicine container 1. The cover 32 can take a first position (FIGS. 1 to 4) covering the medicine container 1 and a second position (FIGS. 8 to 12) where the medicine container 1 can be removed. Below, for convenience of explanation, the support 3 will be described with reference to both the case where the support 3 can take the first position and the case where the support 3 can take the second position. First, the support body 31 will be described.

  The support body 31 is a plate-like member in which an upper end portion 311, an intermediate portion (first support portion) 312, and a lower end portion (second support portion) 313 are integrally formed. In addition, a plate-like holding portion 314 is connected between the upper end portion 311 and the intermediate portion 312. The upper end portion 311 is formed in a plate shape having a trapezoidal shape when viewed from the front, and an annular attachment portion 315 protruding to the back side is formed at the center thereof. As shown in FIG. 12, the attachment portion 315 has a notch 3151 formed on the lower side, and a shaft portion of the fixing portion 4 described later is attached to the hole of the attachment portion 315 from the notch 3151. Further, on the left and right sides of the upper end portion 311, a first locking portion 3111 is formed on the front side, and a second locking portion 3112 is formed on the back side. The first locking portion 3111 is disposed on the intermediate portion 312 side, and the second locking portion 3112 is disposed above the first locking portion 3111. A part of the cover 32 to be described later is sandwiched between the first locking portion 3111 and the second locking portion 3112. A hinge 316 is formed on the upper side of the upper end portion 311, and the cover 32 is swingably attached via the hinge 316.

  The intermediate portion 312 is formed in a plate shape having a rectangular shape when viewed from the front, and is connected to the lower end of the upper end portion 311. And as above-mentioned, the holding | maintenance part 314 which hold | maintains the neck part 12 of the chemical | medical agent container 1 is connected between the upper end part 311 and the intermediate part 312. The holding portion 314 includes a pair of holding pieces 3141a and 3141b formed in a plate shape, and these holding pieces 3141 extend forward. These holding pieces 3141 are arranged with a gap in the center in the left-right direction, and the neck 12 of the drug container 1 is held in this gap. More specifically, the gap between the holding pieces 3141a and 3141b is formed in a circular shape in plan view along the outer peripheral surface of the neck 12, but the gap between the front ends of the holding pieces 3141a and 3141b is It is narrower than the diameter of the neck 12. As a result, the neck 12 is prevented from coming off. The length in the front-rear direction of the holding part 314 is preferably longer than half of the width in the front-rear direction of the medicine container 1.

  The intermediate portion 312 is configured to contact the back surface 114 of the drug container 1 and extends from the upper end of the main body portion 11 of the drug container 1 to the vicinity of the intermediate portion in the vertical direction of the main body portion 11. More specifically, as shown in FIG. 10, the intermediate portion 312 extends downward beyond the vertical position corresponding to the center of gravity G of the medicine container 1.

  The lower end 313 is formed in a rectangular plate shape in a front view extending downward from the lower end of the back surface of the intermediate portion 312. Thereby, the lower end portion 313 is disposed behind the intermediate portion 312 and a gap is formed between the lower end portion 313 and the back surface 114 of the medicine container 1 that is in contact with the intermediate portion 312. Further, the width of the lower end portion 313 in the left-right direction is narrower than that of the intermediate portion 312. When the drug container 1 is held by the holding portion 314, the lower end portion 313 is seen from the front by being blocked by the drug container 1. There is no such thing. A bar-shaped protrusion 317 extending in the vertical direction is formed at the center of the front surface of the lower end 313, and the front surface of the protrusion 317 is located behind the front surface of the intermediate portion 312. In addition, a plate-like bottom surface support portion 318 having a rectangular shape in plan view is connected to the lower end edge of the lower end portion 313. The bottom surface support portion 318 protrudes forward with substantially the same length as the holding portion 314 and is configured to contact the bottom surface 111 of the drug container 1.

  Next, the cover 32 will be described. The cover 32 is connected to the support body 31 via the hinge 316, so that the first position in use covers the drug container 1 as described above, and the second position when the drug container 1 is attached or removed. Can take.

  The cover 32 includes a front wall portion (first wall surface) 321 disposed on the front side of the support body 31, an upper wall portion (second wall surface) 322 that is connected to the upper edge of the front wall portion 321 and extends in the front-rear direction, A back wall portion 323 extending in the vertical direction from the rear end edge of the upper wall portion 322 and surrounding the periphery of the upper end portion 311 of the support body 31.

  The front wall portion 321 is formed in a rhombus shape when viewed from the front, and the front surface is decorated. The front wall portion 321 is formed in such a size that the medicine container 1 held by the support body 31 is substantially hidden. The upper wall portion 322 is formed in a square shape in front view so as to follow the upper end portion of the front wall portion 321 and is disposed so as to cover the liquid absorbent core 2 inserted into the medicine container 1 from above. An opening is formed in the vicinity of the upper end of the upper wall portion 322, and a plurality of rod-like members 3221 extending in the front-rear direction are arranged in parallel so as to close a part of the opening. The interval at which the rod-shaped members 3221 are arranged is smaller than the diameter of the liquid absorbent core 2. Thereby, from the upper wall part 322, although the chemical | medical agent volatilized from the liquid absorption core 2 passes, the liquid absorption core 2 does not come out.

  The back wall portion 323 is formed in a square shape in front view so as to follow the rear end edge of the upper wall portion 322, and as described above, the back wall portion 323 has a plate shape so as to surround the periphery of the upper end portion 311 of the support body 31. Is formed. First, the upper side of the upper end portion 311 of the support body 31 is connected to the back wall portion 323 via a hinge 316. Further, the inner peripheral edges on both sides of the back wall portion 323 are sandwiched between a first locking portion 3111 and a second locking portion 3112 formed on the upper end portion 311 of the support body 31. Thereby, the back wall part 323 is fixed to the support main body 31, and the cover 32 is hold | maintained in a 1st position.

  Next, the case where the cover 32 is in the second position will be described. In the first position, as shown in FIGS. 1 to 4, since the cover 32 covers the drug container 1, the front wall portion 321 is arranged to extend in the vertical direction so as to be substantially parallel to the support body 31. If the front wall portion 321 is inclined upward from this state, the locked state of the first locking portion 3111 and the second locking portion 3112 and the back wall portion 323 is released, and the cover 32 causes the hinge 316 to move. It can swing around the center. Then, for example, as shown in FIG. 10, the cover 32 swings to a state where the front wall portion 321 extends horizontally above the support body 31 and assumes the second position. In this state, since the medicine container 1 is exposed to the outside, it can be removed.

<4. Fixed part>
Next, the fixing part 4 will be described with reference to FIG. FIG. 13 is a side view of the fixing portion. The fixing portion 4 is formed so as to extend from the attachment portion 315 of the upper end portion 311 in the support body 31 to the back side. More specifically, a connecting portion 43 that is rotatably connected to the attachment portion 315, a plate-like first fixing piece 41 that extends rearward from the connecting portion 43, and a lower side of the first fixing piece 41 in parallel. And a plate-like second fixing piece 42 extending, and these are integrally formed. The connecting portion 43 includes a small-diameter shaft portion 431 and a circular retaining portion 432 that is attached to the front side of the shaft portion 431 and has a diameter larger than that of the shaft portion 431. The shaft portion 431 is cut into a hole of the attachment portion 315. It is attached via a notch 3151. The inner diameter of the attachment portion 315 is substantially the same as that of the shaft portion 431, but is smaller than the retaining portion 432, so that the connecting portion 43 is attached to the attachment portion 315 so as to be rotatable around an axis extending in the front-rear direction. Further, since the width of the notch 3151 is smaller than the diameter of the shaft portion 431, the notch 3151 serves to prevent the shaft portion 431 from coming off. At this time, the connecting portion 43 rotates with respect to the attachment portion 315 with almost no resistance. For example, when the support body 3 receives vibration, the support body 3 is in contact with the fixed portion 4. It is designed to rotate.

  The first fixed piece 41 and the second fixed piece 42 can be elastically deformed with respect to the connecting portion 43, whereby both the fixed pieces 41 and 42 can be deformed so as to be close to each other. In the initial state, the rear ends of the fixed pieces 41 and 42 are in contact with each other, and the object to be attached is elastically placed between the fixed pieces 41 and 42 by pushing it against the elastic force. It can be pinched.

<5. Usage of chemical volatilizer>
Next, the usage method of the chemical volatilizer comprised as mentioned above is demonstrated. First, the cap of the medicine container 1 is removed, and the liquid absorption core 2 is exposed. Subsequently, the cover 32 of the support 3 is opened to the second position, and the holding portion 314 is exposed. Following this, the neck portion 12 of the drug container 1 is inserted between the holding pieces 3141a and 3141b of the holding portion 314. Specifically, the inner edges of both holding pieces 3141a and 3141b are engaged with the gap between the protrusion 13 of the neck 12 and the upper surface 115 of the main body 11. In this state, the gap on the front end side of both holding pieces 3141a and 3141b is narrower than the diameter of the neck portion 12, so that this prevents the neck portion 12 from being detached from the holding portion 314. Thus, when the neck portion 12 is attached to the holding portion 314, the back surface 114 of the main body portion 11 of the drug container 1 comes into contact with the intermediate portion 312 of the support main body 31, and the bottom surface 111 of the main body portion 11 contacts the bottom surface support portion 318. Abut.

  As described above, the holding portion 314 engages with the gap between the protruding portion 13 of the neck portion 12 and the upper surface 115 of the main body portion 11, but when this shifts in any of the vertical directions, the bottom surface 111 of the main body portion 11 becomes the bottom surface support portion. For example, the main body portion 11 hits the bottom surface support portion 318 so that the medicine container 1 cannot be attached to the support body 3. Therefore, the bottom surface support part 318 also functions as a guide for mounting the medicine container 1 at the correct position.

  Thus, when the medicine container 1 is mounted, the cover 32 is returned to the first position. Thereby, the drug container 1 is prevented from moving forward by the front wall portion 321 of the cover 32 and is prevented from being detached from the support body 31. Moreover, since the upper wall part 322 of the cover 32 covers the liquid absorption core 2 from above, it is possible to prevent the liquid absorption core 2 from being detached from the drug container 1.

  Subsequently, the fixing portion 4 is attached to the attachment target portion. That is, the attachment object is sandwiched between the two fixing pieces 41 and 42 of the fixing portion 4. Thus, the attachment of the chemical volatilizer is completed. In addition, although an attachment target object is not specifically limited, For example, it can be accompanied by vibration, such as an air-conditioner of a motor vehicle, or an exhaust port of a defroster. However, the object to be vibrated may be other than the exhaust port as described above, and is not particularly limited.

  Thereafter, the drug in the drug container 1 is sucked up by the liquid absorption core 2, and is evaporated to the outside of the drug container 1 through the liquid absorption core 2. Thereby, an aroma effect etc. can be acquired. And in the chemical volatilizer which concerns on this embodiment, even if the quantity of the chemical | medical agent in the chemical | medical agent container 1 decreases for the following reasons, a chemical | medical agent can be used up to the last. First, the lower end 21 of the liquid absorbent core 2 is in contact with the bottom surface 111 of the drug container 1, and at least a part of the lower end 21 of the liquid absorbent core 2 is in contact with the edge 1111 of the bottom surface 111. Therefore, among the drugs that have flowed down from the side surface 112 and reached the bottom surface 111, the drug remaining near the edge of the bottom surface 111 due to surface tension can also be aspirated. Further, since the ridge 16 having a groove is formed from the side surface 112 to the bottom surface 111 of the main body portion 11, the medicine easily flows down to the bottom surface 111 by passing through the ridge 16. As a result, the medicine that has flowed down by the liquid absorbent core 2 can be easily sucked up. Further, for example, when the medicine container 1 is turned upside down, the medicine accumulates on the upper surface 115 of the main body portion 11, but this medicine flows along the protrusions 17 a and 17 b of the upper surface 115 to the neck portion 12, and the absorbent core. 2 is aspirated.

  Thus, since the liquid absorption core 2 is in contact with the edge of the bottom surface 111 and the protrusions 16 and 17 are formed, in the drug container 1 of the present embodiment, the drug remains in the container. Can be prevented, and the medicine can be used up to the end.

<6. Features>
As described above, this embodiment has the following features.

<6-1>
Since the neck portion 12 of the medicine container 1 that contains the medicine is held by the holding portion 314 of the support 3 so as to be sandwiched from the left and right, even if the medicine container 1 is subjected to vibration from the lateral direction, The separation from the support can be prevented. As a result, the medicine can be prevented from spilling from the medicine container 1.

<6-2>
A protrusion 13 is formed on the outer peripheral surface of the neck portion 12, and the 314 holding portion engages with a gap between the protrusion 13 and the upper surface 115 of the main body 11, so that the movement of the medicine container 1 in the vertical direction is restricted. Is done. Therefore, it is possible to prevent the medicine container 1 from being detached from the support body 3 even when the medicine container 1 receives vertical vibrations.

<6-3>
Since the main body part 11 of the medicine container 1 is sandwiched between the holding part 314 and the bottom surface support part 318 in the vertical direction, once the medicine container 1 is mounted on the support body 3, The medicine container 1 cannot be moved obliquely upward or obliquely downward, so that the medicine container 1 can be prevented from being detached.

<6-4>
The entire outer peripheral surface of the main body part 11 of the drug container 1 is not supported by the support body 31, but the drug container 1 contacts the intermediate part 312 of the support body 31 and leaves a gap with the lower end part 313. Yes. Therefore, even if the medicine container 1 receives vibration, at least a part of the vibration can be absorbed by the gap with the lower end 313. As a result, the drug container 1 can be prevented from being damaged by the impact from the support body 31 when subjected to vibration. Moreover, since the rod-shaped protrusion 317 is formed in the lower end part 313, when the chemical | medical agent container 1 moves to the clearance gap side, this protrusion 317 contacts as a cushion.

  Further, since the intermediate portion 312 is in contact with the outer peripheral surface of the main body portion 11 of the drug container 1 at the vertical position corresponding to the center of gravity G of the drug container 1, when the vibration is received (particularly in the drug container) Even when the remaining amount of the medicine is low), the medicine container 1 can be prevented from shaking greatly with respect to the support body 31.

<6-5>
Since the fixing part 4 is rotatably attached to the support body 3, the following effects are obtained. That is, when the support 3 receives vibration, the support 3 rotates with respect to the fixed portion 4. Therefore, for example, even if the attachment object 7 is changed from the horizontal state shown in FIG. 14 (a) to the inclined state shown in FIG. 14 (b), the center of gravity of the support 3 is fixed to the support 3 and the fixing portion. The support body 3 rotates so as to be positioned vertically below the connecting portion with the motor 4. Therefore, since the medicine container 1 is maintained with the opening 121 facing upward, it is possible to prevent the medicine from spilling.

<7. Modification>
As mentioned above, although one Embodiment of this invention was described, this invention is not limited to this, A various change is possible unless it deviates from the meaning. The following modifications can be combined as appropriate.

<7-1>
In the above embodiment, the holding portion 314 is engaged between the protruding portion 13 of the neck portion 12 and the upper surface 115 of the main body portion 11, but is not limited thereto. That is, the holding portion 314 can be engaged using the male screw 14 provided on the neck portion 12. Further, the protruding portion 13 of the neck portion 12 does not need to be provided over the entire circumference of the neck portion 12 and may be a part. Furthermore, a plurality of protrusions 13 may be provided in the axial direction of the neck 12, and the holding part 314 may be engaged between the adjacent protrusions 13.

  The form of the holding part 314 is not particularly limited as long as the holding part 314 is held so as to sandwich the neck part from the outside in the radial direction of the neck part. Moreover, it is not restricted to a neck part, It can also hold | maintain so that a main-body part may be pinched | interposed from radial direction outer side.

<7-2>
The form of the support 3 is not particularly limited as long as at least the holding portion 314 is provided. Therefore, a cover may be provided as necessary.

<7-3>
The form of the fixing portion 4 is not particularly limited as long as it can be fixed to the attachment target. Further, the support 3 can be directly fixed to the attachment object with a double-sided tape or the like without providing the fixing portion.

<7-4>
The form of the medicine container 1 is not particularly limited as long as the medicine container 1 has an opening 121 at least at the top, and the liquid absorbent core 2 can be inserted so as to be impregnated with the medicine from the opening 121. Accordingly, the shape, material, etc. are not particularly limited.

<7-5>
The protrusions 16, 17a, 17b formed in the medicine container 1 are formed to transmit medicine, but are not limited thereto. For example, although the grooves 16, 17 a, and 17 b are formed with grooves, the grooves are not necessarily provided, and only the protrusions 17 may be provided as shown in FIG. 15. In the above embodiment, the protrusions are formed from the bottom surface 111 to the side surface 112 of the drug container 1 (16) and from the top surface 115 to the neck portion 12 (17a, 17b). That's fine. Also, a plurality of protrusions can be provided. Further, instead of the protrusions, grooves 18 can be formed on the inner wall surface of the medicine container 1 as shown in FIG.

<7-6>
In the above embodiment, as shown in FIG. 6, the lower end portion 21 of the liquid absorbent core 2 is in contact with the left and right edge portions 1111 of the bottom surface 111 of the drug container. For example, as shown in FIG. 17 (a), the diameter of the lower end portion 21 of the liquid absorbent core 2 may be small and may be in contact with only one edge portion 1111 or as shown in FIG. 17 (b). It may be in contact with any one of the edges 111 (the back side in this example). Further, the shape of the bottom surface 111 is not particularly limited as long as a part of the lower end portion 21 of the liquid absorbent core 2 is in contact with any one of the edge portions. However, such a configuration is not necessarily required, but is preferably provided.

1: Drug container 11: Main body 111: Bottom surface 112: Side surface (outer peripheral surface)
113: Front surface (outer peripheral surface)
114: Back surface (outer peripheral surface)
115: Upper surface (outer peripheral surface)
12: Neck part 121: Opening 13: Projection part 2: Liquid absorption core 21: Lower end part 3: Support body 31: Support body (upper and lower support part)
312: Intermediate part (first support part)
313: Lower end portion (second support portion)
314: Holding portion 318: Bottom support portion 32: Cover 4: Fixing portion G: Center of gravity

Claims (8)

A drug container having an opening at the top and containing a liquid drug;
A liquid absorbent core to be inserted into the opening of the drug container;
Supporting the drug container, and a support attached to the attachment object;
With
The said support body is provided with the holding | maintenance part hold | maintained so that the said medicine container may be pinched | interposed from the radial direction outer side with respect to the axial direction of the said opening. The drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part,
The drug volatilizer according to claim 1, wherein the holding part is configured to hold the neck part. A protrusion is formed on the outer peripheral surface of the neck,
The chemical volatilizer according to claim 2, wherein the holding unit is engaged with a gap between the protrusion and the main body. The support is
A first wall surface covering the drug container from the side opposite to the side where the holding unit is provided;
A second wall surface covering the opening side into which the liquid absorption core is inserted, and further comprising a cover,
The chemical volatilizer according to any one of claims 1 to 3, wherein the second wall surface is configured to allow gas to pass therethrough. The drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part,
The holding part is configured to hold the neck part,
The support is
A first support portion in contact with the outer peripheral surface of the main body portion at a vertical position corresponding to the center of gravity of the medicine container;
5. The apparatus according to claim 1, further comprising: a second support portion that is connected to the first support portion and is disposed below the first support portion and spaced from the main body portion. The chemical volatilizer as described. The drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part,
The holding part is configured to hold the neck part,
The support is
An upper and lower support portion that extends in the vertical direction and is connected so that the holding portion extends toward the neck portion, and at least a part of which is in contact with the outer peripheral surface of the main body portion;
5. A bottom support portion connected to a lower end portion of the upper and lower support portions and extending in the same direction as the holding portion so as to support a bottom surface of the main body portion. Chemical volatilizer.   The chemical volatilizer according to any one of claims 1 to 6, further comprising a fixing portion for attaching the support to an attachment object. The drug container includes a bottom surface formed immediately below the opening, and an outer peripheral surface extending upward from a peripheral edge of the bottom surface,
The drug volatilizer according to any one of claims 1 to 7, wherein at least a part of a lower end portion of the liquid-absorbing core is configured to come into contact with any one of the peripheral edges of the bottom surface.

Images